Press Room

Jan 10 2013

Upton, Coburn Commend FDA’s Draft Guidance As Important First Step to Keep Non-Abuse-Deterrent Prescription Drugs From Hitting Market

Leaders Had Expressed Concern with the Prospect of Non-Abuse-Deterrent Versions of Powerful Prescription Drugs Hitting the Market, Making Them Easier to Crush and Abuse

WASHINGTON, DC – Energy and Commerce Committee Chairman Fred Upton (R-MI) and Senator Tom Coburn (R-OK) commended the Food and Drug Administration for meeting today’s deadline to issue draft guidance on abuse-deterrent prescription drugs. In late December, the leaders had requested the Department of Health and Human Services provide more information on its efforts to address the growing concerns surrounding the imminent release of abuse-deterrent versions of extended-release opioids, such as Oxycontin.

In the December letter to HHS, Upton and Coburn wrote, “During the past month, we have heard from a number of concerned citizens, including parents, law enforcement officials, health care providers, state and local officials, and our colleagues in Congress, about the impending release of the non-tamper-resistant versions of these opioids. According to these concerned citizens, the release of the non-tamper-resistant versions will deal a significant setback to our nation’s ongoing struggle to stop prescription drug abuse.”

FDA Commissioner Margaret Hamburg echoed Upton’s and Coburn’s concerns yesterday in responding to their letter, writing, "Please be assured that HHS and FDA share your concerns, and those of your constituents, regarding prescription drug abuse, including the abuse of opioid analgesics. HHS and FDA are committed to finding ways to reduce abuse and misuse of these medications. As part of our ongoing mission to protect public health, FDA has concluded that if FDA determines that a formulation of a product significantly deters abuse, we have legal authority, under the drug approval and drug safety provisions of the Federal Food, Drug, and Cosmetic Act, to require generic versions of that product to have abuse-deterrent formulations as well."

Upton and Coburn commended FDA for meeting today’s deadline set forth in Section 1122 of the Food and Drug Administration Safety and Innovation Act of 2012 by issuing the draft guidance on abuse-deterrent opioids. The leaders stated, “The draft guidance represents an important step forward in understanding how the FDA will apply the science of abuse deterrence when evaluating abuse-deterrent opioid formulations. Prescription drug abuse is a real and constant struggle, and we look forward to working with the agency, law enforcement, health officials, and concerned parents across the nation to adopt policies that curb the abuse of powerful, non-abuse-deterrent prescription drugs.”

A copy of Upton’s and Coburn’s December 21, 2012, letter can be found here.

FDA Commissioner Hamburg’s response to can be found here.


Date Title
12/16/14 Dr. Coburn on Tax Extenders: Washington’s Christmas Tree For Special Interests
12/16/14 Dr. Coburn's Statement on Protecting Veterans and Taxpayers
12/16/14 Senators Baldwin and Coburn Applaud Commitment to Enhance Access to HIV Drugs in Developing Countries
12/16/14 Coburn Introduces Bill to Protect and Strengthen the Social Security Disability Insurance Program
12/9/14 Coburn Releases Report Decoding the Tax Code
Date Title
11/18/14 Reps. Issa, Gingrey, and Sen. Coburn: GAO Study Finds Government’s Data Quality for Official Time is Unreliable
11/10/14 Value of Terrorism Prevention Centers Remains Unproven
Date Title
10/30/14 Wastebook 2014 Videos
10/29/14 Coburn “Concerned” With White House Reaction to Cyber Breach
10/22/14 Wastebook 2014: What Washington doesn't want you to read.
10/1/14 New Report Details Millions Spent on Unnecessary Transport of Surplus Vehicles From Afghanistan
Date Title
9/26/14 GAO: Federal Government Underreports Data Center Cost Savings by Billions
9/23/14 Statement by Senator Tom Coburn on the Recent Washington Post Story about the Department of Homeland Security
9/22/14 GAO: Long-term Viability of DHS Consolidation in Question
9/22/14 Bipartisan Bill to Consolidate Federal IT Infrastructure, Save Up to $3 Billion Passes Senate
9/19/14 Senate Approves Carper, Coburn Legislation to Curb Improper Payments to Deceased Individuals
9/19/14 Bipartisan Legislation Would Require State Representation on Federal Banking Board
9/9/14 Reducing Insurance Subsidies for Wealthy Farmers Could Save Hundreds of Millions Annually
Date Title
8/29/14 New Health Benefit For Temporary Federal Employees May Violate Federal Law
8/28/14 Oklahoma Delegation Responds to Obama Administration’s Failure to Grant ESEA Extension
8/13/14 GAO Report Confirms Need for Additional Oversight of Medicare Claims Reviews
8/12/14 Over 600 Illegal Immigrants with Prior Criminal Convictions Released into the U.S.
8/10/14 Big Banks Claim Millions of Dollars in Tax Credits Intended For Poor Communities
8/8/14 Members Call on OMB Director to Address Concerns of Inspectors General
8/4/14 GAO: $619 Billion in Government Spending Never Disclosed on Transparency Website